Disseminated Tuberculosis in a Psoriasis Patient under Adalimumab Treatment despite the Chemoprophylaxis of Latent Tuberculosis: A Case Report

Recently, biologic therapy has become a major advance in the management of moderate-to-severe psoriasis. Although the overall safety profile of biologics is favorable, primary infection or reactivation of latent tuberculosis (TB) is the major concern in the setting of tumor necrosis factor-alpha inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Oh, Jae Hong, Ham, Seung Pil, Park, Hai-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Dermatological Association; The Korean Society for Investigative Dermatology 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875218/
https://www.ncbi.nlm.nih.gov/pubmed/33911816
http://dx.doi.org/10.5021/ad.2021.33.1.77

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7875218/
https://www.ncbi.nlm.nih.gov/pubmed/33911816
http://dx.doi.org/10.5021/ad.2021.33.1.77

Ejemplares similares